日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Erratum: Development of clinical research networks in rural America: Our experience from the Accelerating COVID-19 Therapeutic Interventions and Vaccines-1 trial - CORRIGENDUM

勘误:美国农村地区临床研究网络的发展:我们从加速 COVID-19 治疗干预和疫苗-1 试验中的经验——更正

Kedar, Eyal; Dandachi, Dima; Bryant, Alexis; Anstrom, Kevin J; Powderly, William

Development of clinical research networks in rural America: Our experience from the Accelerating COVID-19 Therapeutic Interventions and Vaccines-1 trialau

美国农村地区临床研究网络的发展:我们从加速 COVID-19 治疗干预和疫苗-1 试验中汲取的经验

Kedar, Eyal; Dandachi, Dima; Bryant, Alexis; Anstrom, Kevin J; Powderly, William

A first-in-human phase I study of the PD-1 inhibitor, retifanlimab (INCMGA00012), in patients with advanced solid tumors (POD1UM-101)

PD-1 抑制剂 retifanlimab (INCMGA00012) 针对晚期实体瘤患者的首次人体 I 期研究 (POD1UM-101)

N Lakhani, R Cosman, U Banerji, D Rasco, M Tomaszewska-Kiecana, E Garralda, D Kornacki, J Li, C Tian, N Bourayou, J Powderly

SARS-CoV-2 active infection prevalence and seroprevalence in the adult population of St. Louis County

圣路易斯县成年人群中SARS-CoV-2活动性感染率和血清阳性率

Goss, Charles W; Maricque, Brett B; Anwuri, Victoria V; Cohen, Rachel E; Donaldson, Kate; Johnson, Kimberly J; Powderly, William G; Schechtman, Kenneth B; Schmidt, Spring; Thompson, Jeannette Jackson; Trolard, Anne M; Wang, Jinli; Geng, Elvin H

Amphotericin B: current understanding of mechanisms of action

两性霉素B:目前对作用机制的认识

Brajtburg, J; Powderly, W G; Kobayashi, G S; Medoff, G

Amphotericin B: delivery systems

两性霉素B:递送系统

Brajtburg, J; Powderly, W G; Kobayashi, G S; Medoff, G